云南白药品牌怎么样 申请店铺

更新时间:2024-10-27
云南白药是哪个国家的品牌?「云南白药」是 云南白药集团股份有限公司 旗下著名品牌。该品牌发源于云南省昆明市,由创始人王明辉在1993-11-30期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
云南白药怎么样

云南白药由云南民间名医曲焕章先生于1902年创制,问世百年来,以其神奇的疗效被世人誉之为“伤科圣药”、“中华瑰宝”。

1971年,公司前身云南白药厂正式成立,白药开始了专业化生产。公司于1993年在深交所挂牌上市,成为云南省第一家A股上市公司。1996年,公司分别投资控股原云南地州的三家云南白药生产企业,即云南大理州制药厂、云南文山州制药厂和云南丽江药业有限公司,共同组成云南白药集团,对云南白药的生产经营实行“五统一”,为名牌战略的实施奠定了基础。1997年公司经国家批准获得自营进出口权。1999年,红塔成为白药集团第二大股东,实现了股权多元化;同年,云南省医药公司和天紫红药厂以优质资产配股方式进入云南白药集团,集团产业链从生产制造延伸到了药品流通和饮片加工领域。目前,省医药公司已成功改组为云南省医药有限公司,在云南首家通过国家GSP认证。天紫红药厂已改制为云南白药集团原生药材事业部,作为省内唯一的饮片加工企业,已于2003年顺利通过国家GMP认证。

经过30多年的发展,公司已从一个资产不足300万元的生产企业成长为一个总资产22亿多,总销售收入逾32亿元,经营涉及化学原料药、化学药制剂、中成药、中药材、生物制品、保健食品、化妆品及饮料的研制、生产及销售;糖、茶,建筑材料,装饰材料的批发、零售、代购代销;科技及经济技术咨询服务,医疗器械(二类、医用敷料类、一次性使用医疗卫生用品),日化用品等领域的云南省实力最强、品牌最优的大型医药企业集团。公司产品以云南白药系列和田七系列为主,共十种剂型七十余个产品,主要销往国内、港澳、东南亚等地区,并已进入日本、欧美等国家、地区的市场。“云南白药”商标于2002年2月被国家工商行政管理总局商标局评为中国驰名商标。

Yunnan Baiyao was created in 1902 by Mr. Qu Huanzhang, a famous folk doctor in Yunnan Province. It has been known as "the holy medicine of Traumatology" and "the treasure of China" for its magical curative effect for more than 100 years. In 1971, Yunnan Baiyao factory, the predecessor of the company, was officially established and specialized production of Baiyao began. The company was listed on Shenzhen Stock Exchange in 1993 and became the first A-share listed company in Yunnan Province. In 1996, the company invested and controlled three Yunnan Baiyao production enterprises in the former Yunnan Prefecture, namely Yunnan Dalizhou pharmaceutical factory, Yunnan Wenshanzhou pharmaceutical factory and Yunnan Lijiang Pharmaceutical Co., Ltd. to jointly form Yunnan Baiyao group, which implemented "Five Unifications" for the production and operation of Yunnan Baiyao, laying a foundation for the implementation of the famous brand strategy. In 1997, the company obtained the right of self import and export with the approval of the state. In 1999, Hongta became the second largest shareholder of Baiyao group, realizing equity diversification; in the same year, Yunnan pharmaceutical company and Tianzi Hongyao factory entered Yunnan Baiyao group by way of high-quality asset allotment, and the industrial chain of the group extended from production and manufacturing to the field of drug circulation and processing of decoction pieces. At present, the provincial pharmaceutical company has been successfully restructured into Yunnan Pharmaceutical Co., Ltd., the first one in Yunnan to pass the national GSP certification. Tianzihong pharmaceutical factory has been transformed into Yunnan Baiyao Group's original medicine business department. As the only processing enterprise in the province, it has successfully passed the national GMP certification in 2003. After more than 30 years of development, the company has grown from a production enterprise with less than 3 million yuan of assets to a total asset of more than 2.2 billion yuan, with a total sales revenue of more than 3.2 billion yuan. Its business involves the research, production and sales of chemical raw materials, chemical pharmaceutical preparations, Chinese patent medicines, biological products, health food, cosmetics and drinks; It is a large pharmaceutical enterprise group with the strongest strength and the best brand in Yunnan Province in the fields of sugar, tea, building materials, decoration materials wholesale, retail, purchasing and selling on behalf of others; scientific and technological and economic and technological consulting services, medical devices (class II, medical dressings, disposable medical and health products), daily chemical products, etc. The company's products are mainly Yunnan Baiyao series and Tianqi series, with a total of more than 70 dosage forms, which are mainly sold to domestic, Hong Kong, Macao, Southeast Asia and other regions, and have entered the markets of Japan, Europe and the United States and other countries and regions. "Yunnan Baiyao" trademark was awarded as China's well-known trademark by the Trademark Office of the State Administration for Industry and Commerce in February 2002.

本文链接: https://brand.waitui.com/7cc1e882e.html 联系电话:087166350538

千城特选小程序码

7×24h 快讯

特斯拉晋升迈克尔·斯奈德为能源与充电副总裁

10月26日,职业社交网站LinkedIn显示,特斯拉Megapack高级总监迈克尔·斯奈德(Michael Snyder)已获晋升为能源与充电副总裁。斯奈德于2014年6月加入特斯拉,于2022年8月担任Megapack高级主管,领导公司的Megapack项目。(界面)

35分钟前

机构:三季度全球AMOLED手机面板出货量同比、环比双增长

36氪获悉,10月26日,CINNO Research最新报告指出,随着苹果iPhone16系列等高端旗舰机型的发布,第三季度OLED面板的整体需求持续回升。根据CINNO Research统计数据显示,2024年第三季度全球AMOLED智能手机面板出货量约2.2亿片,同比增长25.3%,环比增长0.9%,同比、环比双增长。从柔性面板出货来看,2024年第三季度全球AMOLED智能手机面板中柔性AMOLED智能手机面板占比76.4%,同比下滑2.3个百分点,环比上升4.2个百分点。

35分钟前

上海机场明日将执行2024年冬春航班计划

36氪获悉,据上海机场集团消息,2024年10月27日至2025年3月29日,上海机场将执行2024年冬春航季航班计划。新航季中,上海机场日均计划执行航班2403架次(其中,浦东机场1627架次、虹桥机场776架次)。日均计划执行国内客运航班1646架次(其中,浦东机场915架次、虹桥机场731架次),同比持平;日均计划执行国际、港澳台客运航班561架次(其中,浦东机场516架次,虹桥机场45架次),同比增长5.2%。

35分钟前

加“新能源”减“红利”,公募基金进攻路线图显现

10月25日,公募基金2024年三季报披露完毕。公募基金最新前十大重仓股出炉,分别是宁德时代、贵州茅台、腾讯控股、立讯精密、美的集团、五粮液、紫金矿业、中际旭创、阳光电源、比亚迪。与2024年二季度末相比,阳光电源、比亚迪新进前十大重仓股,中国海洋石油、迈瑞医疗则退出前十大重仓股行列。随着市场在三季度末快速上涨,基金经理操作更为积极,调仓动作明显。整体来看,公募基金加仓了多只新能源龙头股,同时减持了前期涨幅较高的红利个股。(中证网)

35分钟前

哪吒汽车马来西亚首家旗舰店开业

36氪获悉,2024年10月25日,哪吒汽车马来西亚首家旗舰店在吉隆坡隆重开业,当日首批50位车主现场交付。据了解,今年,马来西亚赶超泰国,成为仅次于印度尼西亚的东南亚第二大汽车市场。作为在东南亚广受欢迎的中国造车新势力品牌,哪吒汽车正迅速扩大马来西亚新能源汽车市场,目前已拥有12家经销商,并计划在2024年底前,将经销商网络扩大至20家。另外,哪吒汽车在马来西亚的本地工厂,预计明年正式投产。

35分钟前

本页详细列出关于云南白药的品牌信息,含品牌所属公司介绍,云南白药所处行业的品牌地位及优势。
咨询